GlassScriptPhysician profile
Woojung Lee
NPI 1912352477
$2,384.37
in general payments reported to CMS, 2019-2025
9 companies · $348 in 2025
The $348 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $145 · 2021: $403 · 2022: $244 · 2023: $233 · 2024: $819 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798 · Education: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $797.95 |
| Education | $601.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,265.80 | 2019-2025 | Prostep Mica, Citrefix, Gravity Synchfix |
| Horizon Therapeutics Plc | $560.31 | 2019-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $217.71 | 2024-2025 | Nuzyra |
| Amgen INC. | $168.44 | 2024-2025 | Krystexxa |
| Smith+Nephew, INC. | $87.50 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Uni Cp |
| Pylant Medical | $45.91 | 2024 | |
| Bioventus LLC | $13.88 | 2020 | |
| Tactile Systems Technology INC | $13.81 | 2020 | |
| Merck Sharp & Dohme LLC | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Woojung Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.